Clinical Trial Update: Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast Cancer [Phase 2]

View source ↗

Summary

This report provides an update on a randomized Phase II trial of combining anastrozole with metronomic tegafur-uracil as neoadjuvant therapy for postmenopausal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Tegafur-Uracil (tegafur-uracil)

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Breast Neoplasms | Phase 2 | Status: TERMINATED